U.S. Residential REITs Stock News

Kymera Therapeutics (KYMR) has put several big issues on the table at once, combining fresh fourth quarter and full year 2025 losses with new equity issuance plans and a key leadership hire. See our latest analysis for Kymera Therapeutics. Despite the larger reported losses and fresh equity plans, Kymera’s recent momentum has been strong, with a 27.61% 1 month share price return and a 156.45% 1 year total shareholder return, suggesting investors are reassessing both risk and potential. If...

If you are wondering whether Southwest Airlines' current share price still offers value, this article will walk through what that price might imply about the company. The stock closed at US$49.89 recently, with returns of 18.7% over the last 30 days, 20.8% year to date and 66.1% over the past year, although the last 7 days show a 9.0% decline and the 5 year return sits at a 7.3% loss. Recent coverage has focused on Southwest Airlines as investors reassess US airline stocks generally,...

Ameren Missouri, a subsidiary of Ameren Corporation, has priced a new public offering of first mortgage bonds. The company plans to use the proceeds to refinance existing debt and fund near term capital expenditures. This financing step is intended to reshape Ameren Missouri's debt profile and support upcoming investment needs. For investors watching Ameren (NYSE: AEE), this bond move sits alongside a share price of $111.44 and multi year returns. The stock is up 2.9% over the past week,...

Viatris Inc. recently reported fourth-quarter 2025 results with revenue of US$3,703.6 million and a net loss of US$340.1 million, issued 2026 revenue guidance of US$14.45 billion to US$14.95 billion, and affirmed a 2026 dividend policy of US$0.48 per share. Alongside these results, the company highlighted progress in its ophthalmology pipeline with FDA review of MR-141 for presbyopia and continued cost-saving initiatives aimed at making its operations more focused and efficient. We’ll now...

Tronox Holdings (NYSE:TROX) is expanding further into the rare earth supply chain, signaling a push beyond its traditional titanium dioxide business. The company has filed a universal shelf registration, giving it flexibility to raise capital through a range of securities if and when it chooses. At a share price of $7.2, NYSE:TROX has had a mixed return profile, with a 68.6% gain year to date alongside a 46.9% decline over 3 years and a 52.5% decline over 5 years. Over the past month the...

Wondering if Apollo Global Management at around US$117 per share is starting to look appealing again, or if the recent weakness is a warning sign for value focused investors like you. The stock is down around 6.5% over the last week, 10.9% over the last month and 20.1% year to date, although the 3 year and 5 year returns of 71.3% and 158.5% still show a very different longer term picture. Recent headlines have focused on Apollo's role as a major alternative asset manager and on how investors...

American States Water Company has reported its fourth-quarter and full-year 2025 results, with sales and revenue rising to US$164.28 million for the quarter and US$658.07 million for the year, and full-year net income reaching US$130.44 million. Despite the revenue and annual earnings increases, quarterly diluted earnings per share from continuing operations were essentially flat at US$0.74 compared with US$0.75 a year earlier, highlighting margin pressures even as the business scales. With...

TriNet Group (TNET) just released its fourth quarter and full year 2025 results alongside 2026 guidance, including updated revenue, earnings and share repurchase figures that give investors fresh context for the stock. See our latest analysis for TriNet Group. Despite a 3.92% 1 day share price return taking TriNet Group to US$35.75, the 30 day share price return of 43.12% and 1 year total shareholder return of 49.19% indicate that momentum has been fading as the market absorbs softer 2026...

Elanco Animal Health's Latest Earnings Show Mixed Profitability Signals Elanco Animal Health (ELAN) has wrapped up FY 2025 with fourth quarter revenue of US$1,144 million and basic EPS of a US$0.56 loss, alongside trailing twelve month revenue of US$4.7 billion and basic EPS of a US$0.47 loss. Over recent periods the company has seen quarterly revenue move from US$1,020 million in Q4 2024 to US$1,144 million in Q4 2025, while basic EPS has swung between a profit of US$0.14 in Q1 2025 and a...

If you are wondering whether Liberty Latin America is priced attractively right now, this article will walk through how its current share price stacks up against different ways of thinking about value. The stock closed at US$7.79 most recently, with returns of 0.8% over the last 7 days, 2.2% over 30 days, 7.3% year to date, 12.2% over 1 year, and longer term returns of an 11.0% decline over 3 years and a 40.1% decline over 5 years that many investors will want to put into context. Recent...

Chesapeake Utilities Corporation recently reported fourth-quarter 2025 results showing sales of US$266.6 million and net income of US$46.1 million, alongside a declared quarterly cash dividend of US$0.685 per share payable on April 6, 2026. The company’s full-year 2025 earnings growth, combined with reaffirmed 2028 earnings guidance of US$7.75 to US$8.00 per share and a 65-year uninterrupted dividend record, underlines its emphasis on consistent income generation for shareholders. Next,...

Owens Corning FY 2025 earnings snapshot Owens Corning (OC) has wrapped up FY 2025 with Q4 revenue of US$2,142 million and a basic EPS loss of US$3.45, capping a year where trailing 12 month revenue came in at US$10.1 billion and basic EPS was a loss of US$2.24. Over recent quarters, the company has seen quarterly revenue move from US$2,840 million in Q4 2024 to US$2,530 million in Q1 2025, then US$2,747 million in Q2 and US$2,684 million in Q3. Basic EPS swung between a loss of US$3.00 in Q4...

Dole (DOLE) FY 2025 earnings headline Dole (DOLE) has rounded out FY 2025 with fourth quarter revenue of US$2.4b and basic EPS of a US$0.02 loss, capping a year in which trailing twelve month revenue came in at US$9.2b and EPS at US$1.02. Over recent quarters the company has seen revenue move from US$2.2b in Q4 2024 to US$2.4b in Q4 2025, while quarterly EPS shifted from US$0.23 to a small loss. This leaves investors weighing solid full year earnings power against softer margin execution in...

DMC Global Inc. has reported its fourth-quarter 2025 results, with sales falling to US$143.53 million from US$152.37 million a year earlier and swinging from a small net income to a net loss of US$11.16 million. For full-year 2025, the company reduced its net loss to US$13.45 million despite lower sales of US$609.84 million, but management’s first-quarter 2026 guidance flags continued operational pressures and weather-related disruptions that are expected to weigh on near-term...

In February 2026, Lincoln Educational Services reported Q4 2025 and full‑year results showing higher revenue of US$142.87 million for the quarter and US$518.24 million for the year, alongside net income of US$12.7 million and US$20 million respectively, and issued 2026 guidance calling for revenue of US$580–590 million and diluted EPS of US$0.64–0.74. Beyond the headline earnings beat, management highlighted double‑digit student start growth, rising operating efficiency, and planned campus...

In the fourth quarter and full year ended December 31, 2025, CBRE Group reported higher sales but lower quarterly earnings per share, while also completing a share repurchase program totaling 43,753,374 shares for about US$4.20 billion since its November 2021 authorization. Alongside this capital return, a series of analyst upgrades highlighting CBRE’s positioning for artificial intelligence and resilient brokerage trends has reframed how investors view the company’s longer-term earnings...

Phibro Animal Health (NasdaqGM:PAHC) CEO Jack Bendheim recently sold a substantial block of company shares. The sale followed a strong quarterly performance for Phibro Animal Health. Growth in the Medicated Feed Additives portfolio, supported by recent acquisitions, was a key driver in the latest results. The timing of the insider sale after reported operational progress has drawn attention from investors tracking management actions. Phibro Animal Health focuses on animal health and...

Gladstone Land (LAND) has wrapped up FY 2025 with Q4 total revenue of US$41.6 million, a basic EPS loss of US$0.05, and a net income loss of US$1.8 million, alongside funds from operations of US$0.5 million in losses. Over the last few reported periods, revenue has moved from US$21.2 million in Q4 2024 to US$41.6 million in Q4 2025. Trailing twelve month revenue for the year to Q4 2025 sits at US$88.3 million and basic EPS on the same basis is a loss of US$0.29. For investors, these results...

In February 2026, Visa Inc. expanded its global partnership with Oracle Red Bull Racing and Visa Cash App Racing Bulls while also issuing US$3.00 billion of senior notes maturing between 2029 and 2036 and entering a European e‑invoicing payments collaboration with Banqup SA. At the same time, Visa has been pulled into debates over AI- and stablecoin-driven disruption, regulatory scrutiny in Mexico and the US, and a major swipe-fee settlement, highlighting both its reach and the growing...

If you are wondering whether Intapp is starting to look interesting at its current share price, you are not alone and this article is designed to help you weigh that up. The stock has recently seen a 5.2% decline over the last week, a 44.9% decline over the last month and a 67.3% decline over the past year, which will naturally raise questions about both risk and potential future returns. These moves sit against a backdrop of ongoing coverage of Intapp as a listed software company, with...

Jazz Pharmaceuticals (JAZZ) just released its FY 2025 numbers, reporting Q4 revenue of US$1.2 billion and basic EPS of US$3.33, alongside trailing 12 month revenue of US$4.3 billion and a basic EPS loss of US$5.84. Over recent quarters, the company has reported revenue in a range from US$897.8 million in Q1 2025 to US$1.2 billion in Q4 2025, while quarterly basic EPS has moved between a loss of US$11.74 and a profit of US$4.14. This sets up a story where investors are weighing sizeable top...

Somnigroup International Inc. recently reported fourth quarter and full-year 2025 results, with quarterly sales rising to US$1,868.4 million and net income to US$140.8 million, while also declaring a first-quarter 2026 cash dividend of US$0.17 per share payable on March 19, 2026. Despite higher quarterly revenue and earnings per share, full-year profit was essentially flat and earnings per share fell, raising questions about how effectively Somnigroup is converting its expanding sales base...

Corebridge Financial, the retirement-focused insurer spun off from AIG, recently reported a past-quarter revenue increase of 35.7% year over year, substantially exceeding analyst expectations alongside a strong earnings per share beat. This performance made Corebridge one of the strongest life insurance names on earnings surprise, yet it still appeared to fall short of already elevated investor expectations. Building on this substantial revenue beat, we’ll now examine how the latest results...

If you are wondering whether Honeywell International's current share price is giving you good value or asking too much, you are not alone. The stock last closed at US$242.20, with recent returns of 0.4% over 7 days, 9.5% over 30 days, 23.6% year to date, 24.3% over 1 year and 41.4% over 3 years, compared with 36.9% over 5 years. Recent headlines around Honeywell have focused on its position as a large industrial and technology group, with ongoing attention on how it is exposed to areas like...